Page last updated: 2024-10-20

uracil and Dilatation, Pathologic

uracil has been researched along with Dilatation, Pathologic in 1 studies

2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder

Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
" We aimed to test the hypothesis that the DPP-4 inhibitor, alogliptin, attenuates vascular oxidative stress and thus inhibits abdominal aortic aneurysm (AAA) formation."7.80Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats. ( Bao, W; Hasegawa, T; Hirata, K; Morimoto, K; Okada, K; Okita, Y; Sasaki, N; Yamashita, T, 2014)
" We aimed to test the hypothesis that the DPP-4 inhibitor, alogliptin, attenuates vascular oxidative stress and thus inhibits abdominal aortic aneurysm (AAA) formation."3.80Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats. ( Bao, W; Hasegawa, T; Hirata, K; Morimoto, K; Okada, K; Okita, Y; Sasaki, N; Yamashita, T, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, W1
Morimoto, K1
Hasegawa, T1
Sasaki, N1
Yamashita, T1
Hirata, K1
Okita, Y1
Okada, K1

Other Studies

1 other study available for uracil and Dilatation, Pathologic

ArticleYear
Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats.
    Journal of vascular surgery, 2014, Volume: 59, Issue:4

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Animals; Antioxidants; Aorta, Abdominal; Aortic A

2014